Bone Marrow-Derived Mesenchymal Stem Cells Have Innate Procoagulant Activity and Cause Microvascular Obstruction Following Intracoronary Delivery: Amelioration by Antithrombin Therapy. [electronic resource]
Producer: 20160728Description: 2726-37 p. digitalISSN:- 1549-4918
- Animals
- Blood Coagulation -- drug effects
- Bone Marrow -- metabolism
- Cells, Cultured
- Coronary Vessels -- metabolism
- Female
- Fibrinolytic Agents -- pharmacology
- Humans
- Mesenchymal Stem Cell Transplantation -- adverse effects
- Mesenchymal Stem Cells -- metabolism
- Microvessels -- drug effects
- Myocardial Infarction -- drug therapy
- Swine
- Thromboplastin -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.